Jingjing Wang

发表

Plasma Pharmacokinetic and Heart Distribution Studies of Z-GP-EPI, a Hypocardiotoxic Prodrug of Epirubicin

S. Cai, Fang-Lan Liu, Guang-xue Liu, 2015 .

Acute Toxicity is a Dose-limiting Factor for Intravenous Polymyxin B: A Safety and Pharmacokinetic Study in Healthy Chinese Subjects.

Jian Li, Xiaofen Liu, Jing Zhang, 2021, The Journal of infection.

A Randomized, Double‐Blind, Parallel‐Group, Phase 1 Clinical Trial Comparing the Pharmacokinetic, Safety, and Immunogenicity of the Biosimilar HS016 and the Originator Adalimumab in Chinese Healthy Male Subjects

Jing Zhang, Jicheng Yu, G. Cao, 2020, Clinical pharmacology in drug development.

Safety, Tolerability and Pharmacokinetics of Single Ascending and Multiple Oral Doses of Tegoprazan in Healthy Chinese Subjects

Jing Zhang, Nengneng Cheng, Jicheng Yu, 2020, Clinical Drug Investigation.

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects

Jing Zhang, Lichuan Liu, Yuancheng Chen, 2022, Frontiers in Pharmacology.

Generation of continuous-variable spatial cluster entangled states in optical mode comb

Jing Zhang, Jiangrui Gao, Kui Liu, 2016 .

Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis

Yu Wang, Hai-ling Wang, Hong Yuan, 2023, Frontiers in Pharmacology.

Evaluating ecological vulnerability using the GIS and analytic hierarchy process (AHP) method in Yan’an, China

Kang Hou, Jing Zhang, Xuxiang Li, 2016 .

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen

F. Hu, Xiaofen Liu, Jing Zhang, 2022, Antibiotics.

LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA® in Chinese healthy male subjects

Jing Zhang, Yingying Hu, Qing He, 2023, Frontiers in Pharmacology.

Tolerability, safety, pharmacokinetics and pharmacodynamics of SHR0534, a potent G protein-coupled receptor 40 (GPR40) agonist, at single- and multiple-ascending oral doses in healthy Chinese subjects

Yun Liu, Feng Shao, Juan Chen, 2020, Xenobiotica; the fate of foreign compounds in biological systems.

Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study

Jinghua Yan, Wenhong Zhang, Jing Zhang, 2021, Antimicrobial agents and chemotherapy.

Effects of Different Component Contents of Colistin Methanesulfonate on the Pharmacokinetics of Prodrug and Formed Colistin in Human

Jing Zhang, Yu Wang, Xin Li, 2021, Pharmaceutical Research.

Pharmacokinetics and Safety of Single-Dose Amphotericin B Colloidal Dispersion in Healthy Chinese Subjects and Population Pharmacokinetic/Pharmacodynamic Analysis to Inform Clinical Efficacy in Invasive Infections Caused by Candida albicans.

Wei Zhang, Jing Zhang, Yuancheng Chen, 2021, Clinical therapeutics.

Pharmacokinetic and safety profiles of mesalazine enema in healthy Chinese subjects: A single- and multiple-dose study

Jing Zhang, Yuancheng Chen, Yu-ran Cao, 2024, PloS one.

Pharmacokinetics and safety of mavacamten in healthy Chinese participants with different CYP2C19 phenotypes

Jicheng Yu, Xiaojie Wu, G. Cao, 2024, Clinical and translational science.

A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects

Jing Zhang, G. Cao, Jingjing Wang, 2023, Antimicrobial agents and chemotherapy.